Purpose Salivary duct carcinoma (SDC) of the parotid gland is a highly aggressive and
uncommon tumor. Overexpression of human epidermal growth factor receptor 2 (HER-2) is …

Background. We analyzed the records of patients with malignant salivary gland tumors, as
diagnosed in centers of the Dutch Head and Neck Oncology Cooperative Group, in search …

Salivary duct carcinoma (SDC) is a rare, aggressive malignancy that histologically
resembles high-grade mammary duct carcinoma. Because of the rarity of this entity, data …

Background Salivary duct carcinoma is rare, with distinct morphology and behavior. We
reviewed our institutional experience with salivary duct carcinoma, aiming to characterize …

Background To investigate the role of lymph node density (LND) as an independent
prognostic factor in high‐grade salivary gland cancers. Methods All 87 patients with high …

A strategy based on molecular screening and targeted therapy seems to be the best
approach for treating patients with SGCs, in the future. More data on ICI's efficacy and …

Gene expression profiles were studied in 13 cases of salivary gland carcinoma including
mucoepidermoid carcinoma (MEC), acinic cell carcinoma (ACC), and salivary duct …

The prognostic role of modified Glasgow Prognostic Score (mGPS), neutrophil-to-
lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) in patients with salivary duct …

Background Salivary duct carcinoma (SDC) is a high‐grade salivary malignancy that
frequently occurs as the carcinomatous component of carcinoma ex pleomorphic adenoma …

Purpose Salivary gland carcinomas (SGC) are rare malignancies and data regarding
treatment outcomes stratified by histologic subtype are currently limited. This study aims to …